AKT3 and Epstein-Barr virus infection: These results indicate the clinical utility of AKT3 or FGFR2 as prognostic markers, but the relationship between AKT3 and FGFR2 in PPLELC and whether EBV infection is the initial factor of the AKT3 and FGFR2 overexpression remain unknown.